Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one

EU orphan designation number: EU/3/12/970   
Active ingredient: 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: ICON Clinical Research (U.K.) Limited
Regulatory Division, 2 Globeside, Globeside Business Park, Marlow, Buckinghamshire SL7 1HZ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2012 Centralised Orphan - Designation EMA/OD/138/11 (2012)1535 of 05/03/2012